Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects.

NCT00468689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: SB-751689 oral tablets (100 and 400 ng)
DRUG: Ketoconazole (NIZORAL) oral tablets (200 mg)

Sponsor

GlaxoSmithKline